Azra C. Ghani

Active 1997–2025

Also published as
Azra C Ghani
148
Papers
38,365
Citations
92
h-index
144
i10-index

Citations

Citations per year for Azra C. Ghani1970: 1 citations1974: 1 citations1982: 2 citations1986: 2 citations1990: 2 citations1997: 3 citations1998: 1 citations1999: 12 citations2000: 16 citations2001: 23 citations2002: 26 citations2003: 85 citations2004: 138 citations2005: 127 citations2006: 111 citations2007: 77 citations2008: 61 citations2009: 181 citations2010: 215 citations2011: 174 citations2012: 161 citations2013: 245 citations2014: 240 citations2015: 260 citations2016: 230 citations2017: 186 citations2018: 191 citations2019: 588 citations2020: 2,310 citations2021: 2,026 citations2022: 1,436 citations2023: 967 citations2024: 1,038 citations2025: 348 citations2026: 21 citations1971–1973: no citations, so these years are not shown1975–1981: no citations, so these years are not shown1983–1985: no citations, so these years are not shown1987–1989: no citations, so these years are not shown1991–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,575 citing papers, 18.5% of this breakdownUnited Kingdom: 2,490 citing papers, 12.9% of this breakdownChina: 958 citing papers, 4.9% of this breakdownAustralia: 739 citing papers, 3.8% of this breakdownFrance: 626 citing papers, 3.2% of this breakdownSwitzerland: 594 citing papers, 3.1% of this breakdownGermany: 548 citing papers, 2.8% of this breakdownItaly: 518 citing papers, 2.7% of this breakdownCanada: 474 citing papers, 2.4% of this breakdownNetherlands: 455 citing papers, 2.4% of this breakdownIndia: 431 citing papers, 2.2% of this breakdownSpain: 411 citing papers, 2.1% of this breakdown
0%18.5%Other 39%

Fields

  • Medicine58.6%
  • Mathematics21.9%
  • Biochemistry, Genetics and Molecular Biology4%
  • Social Sciences2.7%
  • Immunology and Microbiology2.5%
  • Psychology1.9%
  • Other8.4%

Topics

  • COVID-19 epidemiological studies11%
  • SARS-CoV-2 and COVID-19 Research7.7%
  • Malaria Research and Control7.6%
  • COVID-19 Clinical Research Studies5.6%
  • Mosquito-borne diseases and control5.1%
  • Influenza Virus Research Studies2.7%
  • Other60.3%

Coauthors

All papers

Open in search
  1. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study

    Authors: , , , , , - The Lancet Infectious Diseases 2022 cited by 1,828

  2. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William D. Green, Timothy B. Hallett, Arran Hamlet, Wes Hinsley, B Jeffrey, Edward Knock, Daniel J. Laydon, Gemma Nedjati‐Gilani, Pierre Nouvellet, Kris V. Parag, Igor Siveroni, Hayley A Thompson, Robert Verity, Erik Volz, Caroline E. Walters, Haowei Wang, Yuanrong Wang, Oliver J. Watson, Peter Winskill, Xiaoyue Xi, Patrick Walker, Azra C. Ghani, Christl A. Donnelly, Steven Riley, Michaela Vollmer, Neil M. Ferguson, Lucy Okell, Samir Bhatt - Nature 2020 cited by 3,841

  3. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Samir Bhatt, Paula Blomquist, Asad Zaidi, Erik Volz, Nurin Abdul Aziz, Katie Harman, Sebastian Funk, Sam Abbott, Russell Hope, Andre Charlett, Meera Chand, Azra C Ghani, Shaun R Seaman, Gavin Dabrera, Daniela De Angelis, Anne M Presanis, Simon Thelwall, Russell Hope, Andre Charlett, Meera Chand, Azra C Ghani, Shaun R Seaman, Gavin Dabrera, Daniela De Angelis, Anne M Presanis, Simon Thelwall - The Lancet 2022 cited by 1,294

  4. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - 2022 cited by 1,226

  5. Estimates of the severity of coronavirus disease 2019: a model-based analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christl A. Donnelly, Azra C. Ghani, Neil M. Ferguson - The Lancet Infectious Diseases 2020 cited by 4,164

  6. Global technical strategy for malaria 2016–2030

    Authors: , , , , , , , , , , , , , , , , - 2015 cited by 976

  7. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Haw, Sarah Hayes, Wes Hinsley, Natsuko Imai, Daniel J. Laydon, Tara D. Mangal, Thomas A. Mellan, Swapnil Mishra, Gemma Nedjati‐Gilani, Kris V. Parag, Hayley A Thompson, H. Juliette T. Unwin, Michaela Vollmer, Caroline E. Walters, Haowei Wang, Yuanrong Wang, Xiaoyue Xi, Neil M. Ferguson, Lucy Okell, Thomas S. Churcher, Nimalan Arinaminpathy, Azra C. Ghani, Patrick Walker, Timothy B. Hallett - The Lancet Global Health 2020 cited by 939

  8. Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pedro Aíde, Jahit Sacarlal, John J. Aponte, Patricia Njuguna, Kevin Marsh, Philip Bejon, Eleanor M. Riley, Azra C. Ghani - The Lancet Infectious Diseases 2015 cited by 363

  9. Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Science 2009 cited by 1,969

  10. The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sarah Hayes, Wes Hinsley, Natsuko Imai, David Jorgensen, Edward Knock, Daniel J. Laydon, Swapnil Mishra, Gemma Nedjati‐Gilani, Lucy Okell, H. Juliette T. Unwin, Robert Verity, Michaela Vollmer, Caroline E. Walters, Haowei Wang, Yuanrong Wang, Xiaoyue Xi, David G. Lalloo, Neil M. Ferguson, Azra C. Ghani - Science 2020 cited by 1,099

  11. The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2020 cited by 121

  12. Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study

    Authors: , , , , , , , , , , , , , , , , - The Lancet 2021 cited by 171

  13. Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models

    Authors: , , , , , , , , , , , , , , , - The Lancet 2015 cited by 246

  14. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control

    Authors: , , , , , - Nature Communications 2012 cited by 700

  15. Reducing Plasmodium falciparum Malaria Transmission in Africa: A Model-Based Evaluation of Intervention Strategies

    Authors: , , , , , , , , , , - PLoS Medicine 2010 cited by 626

  16. Drug-Resistance and Population Structure of Plasmodium falciparum Across the Democratic Republic of Congo Using High-Throughput Molecular Inversion Probes

    Authors: , , , , , , , , , , , , , , , , - The Journal of Infectious Diseases 2018 cited by 147

  17. THE IMPORTANCE OF MOSQUITO BEHAVIOURAL ADAPTATIONS TO MALARIA CONTROL IN AFRICA

    Authors: , , , , , , , , , , , , - Evolution 2013 cited by 354

  18. Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis

    Authors: , , , , , , , , , , , , , , , , , , , - Vaccine 2021 cited by 114

  19. Household Transmission of 2009 Pandemic Influenza A (H1N1) Virus in the United States

    Authors: , , , , , , , - New England Journal of Medicine 2009 cited by 492

  20. Comparison of diagnostics for the detection of asymptomatic Plasmodium falciparum infections to inform control and elimination strategies

    Authors: , , , , , , - Nature 2015 cited by 268

  21. Estimates of the changing age-burden of Plasmodium falciparum malaria disease in sub-Saharan Africa

    Authors: , , - Nature Communications 2014 cited by 253

  22. Potential for reduction of burden and local elimination of malaria by reducing Plasmodium falciparum malaria transmission: a mathematical modelling study

    Authors: , , , , , , , , , , - The Lancet Infectious Diseases 2016 cited by 157

  23. Key epidemiological drivers and impact of interventions in the 2020 SARS-CoV-2 epidemic in England

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marc Baguelin - Science Translational Medicine 2021 cited by 141

  24. Epidemiology, transmission dynamics and control of SARS: the 2002–2003 epidemic

    Authors: , , , , , , , , - Philosophical Transactions of the Royal Society B Biological Sciences 2004 cited by 531